← Leaderboards
Merrill D Benson
Indiana Univ-Purdue Univ At Indianapolis
$1,208,022
Attributed
$1,208,022
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $53K · FY2005–21$100K$75K$50K$25K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$1,208,022 · 7
VA$0 · 2
By mechanism
R01$1,019,699 · 1
M01$168,323 · 5
R13$20,000 · 1
I01$0 · 2
Top collaborators
No co-investigators on record.
Most similar at Indiana Univ-Purdue Univ At Indianapolis
Same institution · by research overlap
- Barbara Kluve-Beckerman$1,597,288
- Xiaofeng Frank Yang$8,764,075
Others in their field
Top investigators on “Amyloidosis”
- Eric Martin McDade · Washington University$98,616,192
- David Heimbrook · Leidos Biomedical Research, Inc.$56,561,099
- Randall J Bateman · Washington University$36,953,256
- Jeffery W Kelly · Scripps Research Institute$27,835,242
- Clifford Jack · University Of California Berkeley$17,085,178
- David Eisenberg · University Of California Los Angeles$13,649,212
Research focus
AmyloidosisClinical ResearchHuman SubjectAmyloid ProteinsAmyloidPathologic ProcessPrognosisPathogenesisSign /SymptomBiomarkerOrganHepaticBloodBaseAmyloid FormationFamilial Mediterranean FeverDepositionChronicAmyloid Fibril FormationExtracellularAmyloid FibrilsComplicationAntisense OligonucleotidesAmyloid Deposition
Grant awards (25)
Pathogenesis and Treatment of AA Amyloidosis$0
I01 · FY2021 · VA · contact PI
Pathogenesis and Treatment of AA Amyloidosis$0
I01 · FY2020 · VA · contact PI
Pathogenesis and Treatment of AA Amyloidosis$0
I01 · FY2019 · VA · contact PI
Pathogenesis and Treatment of AA Amyloidosis$0
I01 · FY2018 · VA · contact PI
XIV International Symposium on Amliodosis$20,000
R13 · FY2014 · DK · contact PI
Reactive (AA)Amyloidosis$0
I01 · FY2014 · VA · contact PI
Reactive (AA)Amyloidosis$0
I01 · FY2013 · VA · contact PI
Reactive (AA)Amyloidosis$0
I01 · FY2012 · VA · contact PI
Reactive (AA)Amyloidosis$0
I01 · FY2011 · VA · contact PI
CLINICAL STUDY OF PRESENTATION AND PROGNOSIS OF HUMAN AMYLOIDOSIS$2,617
M01 · FY2008 · RR · contact PI
CLINICAL STUDY OF PRESENTATION AND PROGNOSIS OF HUMAN AMYLOIDOSIS$30,802
M01 · FY2007 · RR · contact PI
CLINICAL STUDY OF PRESENTATION AND PROGNOSIS OF HUMAN AMYLOIDOSIS$42,018
M01 · FY2006 · RR · contact PI
CLINICAL STUDY OF PRESENTATION AND PROGNOSIS OF HUMAN AMYLOIDOSIS$53,015
M01 · FY2005 · RR
Clinical Study of Presentation and Prognosis of Human Amyloidosis$39,871
M01 · FY2004 · RR
PATHOGENESIS OF HEREDITARY TRANSTHYRETIN AMYLOIDOSIS$260,750
R01 · FY2003 · DK
PATHOGENESIS OF HEREDITARY TRANSTHYRETIN AMYLOIDOSIS$254,380
R01 · FY2002 · DK
CLINICAL STUDY OF PRESENTATION AND PROGNOSIS OF HUMAN AMYLOIDOSIS$0
M01 · FY2002 · RR
PATHOGENESIS OF HEREDITARY TRANSTHYRETIN AMYLOIDOSIS$243,600
R01 · FY2001 · DK
CLINICAL STUDY OF PRESENTATION AND PROGNOSIS OF HUMAN AMYLOIDOSIS$0
M01 · FY2001 · RR
PATHOGENESIS OF HEREDITARY TRANSTHYRETIN AMYLOIDOSIS$260,969
R01 · FY2000 · DK
CLINICAL STUDY OF PRESENTATION AND PROGNOSIS OF HUMAN AMYLOIDOSIS$0
M01 · FY2000 · RR
CLINICAL STUDY OF PRESENTATION AND PROGNOSIS OF HUMAN AMYLOIDOSIS$0
M01 · FY2000 · RR
CLINICAL STUDY OF PRESENTATION AND PROGNOSIS OF HUMAN AMYLOIDOSIS$0
M01 · FY2000 · RR
CLINICAL STUDY OF PRESENTATION AND PROGNOSIS OF HUMAN AMYLOIDOSIS$0
M01 · FY2000 · RR
CLINICAL STUDY OF PRESENTATION AND PROGNOSIS OF HUMAN AMYLOIDOSIS$0
M01 · FY2000 · RR